CD8A and viral infectious disease: Therefore, the in vitro generated AlloHSC-iNKT cells, which display a dominant CD8+ SP/DN phenotype, seem fit for application in both cancer therapy and virus infection treatment, although the biological regulations leading to this phenotype remain to be determined.